0001209191-22-042038.txt : 20220713
0001209191-22-042038.hdr.sgml : 20220713
20220713160545
ACCESSION NUMBER: 0001209191-22-042038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220712
FILED AS OF DATE: 20220713
DATE AS OF CHANGE: 20220713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harford Simon N.R.
CENTRAL INDEX KEY: 0001443705
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 221081136
MAIL ADDRESS:
STREET 1: AVON PRODUCTS, INC.
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-12
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001443705
Harford Simon N.R.
C/O ALBIREO PHARMA, INC.
53 STATE STREET, 19TH FLOOR
BOSTON
MA
02109
0
1
0
0
CFO and Treasurer
Common Stock
2022-07-12
4
S
0
95
24.0276
D
33585
D
Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Represents 7,890 shares of common stock and 25,695 restricted stock units.
/s/ Jason Duncan, Attorney-in-fact
2022-07-13